Neoss Inc. Expands Biomaterials Portfolio
Neoss Inc., a leader in innovative dental implant solutions, has exciting news for dental practitioners. They are proud to introduce the NeoGenix™ Extraction Allograft, a groundbreaking addition to their biomaterials line. This new product is crafted entirely from 100% human allograft bone fiber and bone particulate, aiming to enhance bone regeneration effectively for diverse dental practices.
Introducing NeoGenix Extraction Allograft
The NeoGenix Extraction Allograft is meticulously formulated to facilitate a streamlined approach for clinicians. By utilizing a precise composition of demineralized bone fibers and mineralized bone particulate, it creates a supportive environment that promotes stronger and swifter bone growth. This innovative allograft amalgamates both cortical and cancellous materials into an easily manageable plug shape, thereby simplifying the application process.
Efficiency and Practicality for Dentists
One of the most significant benefits of the NeoGenix Extraction Allograft is its efficiency. Dental professionals no longer need to mix particulate grafts or apply additional membranes, which typically complicates procedures. By minimizing the steps involved, Neoss has designed a product that is not only user-friendly but also effective in achieving desirable outcomes.
Expert Insights from Neoss Leadership
John Chopack, the Managing Director of Neoss, shares his enthusiasm about the launch of the NeoGenix product. He emphasizes the cost-effective nature of this allograft and its role in facilitating faster, stronger bone growth. This innovation not only safeguards the patient’s bone structure but also ensures that future implant treatment options remain viable, ultimately benefiting long-term dental health.
Comparative Advantages of NeoGenix
The NeoGenix Extraction Allograft stands out as a dependable and economical alternative to traditional xenografts and synthetic options. With its focus on practicality and clinical effectiveness, it empowers dental professionals to provide high-quality care with ease. This one-step solution is set to redefine patient treatment protocols, ensuring a seamless experience for both clinicians and patients alike.
About Neoss
Neoss prides itself on offering intuitive, intelligent products designed for dental professionals. Their commitment is to provide reliable and cost-effective treatments, which leads to excellent long-term patient outcomes. Respected for their innovation and integrity, Neoss continuously works to establish new benchmarks in the dental field. By developing smarter treatment solutions and collaborating closely with practices, they aim to simplify complex procedures, a philosophy they call 'Intelligent Simplicity'. With headquarters in Harrogate, UK, and research facilities in Gothenburg, Sweden, Neoss maintains a strong global presence across key markets.
Frequently Asked Questions
What is the NeoGenix Extraction Allograft?
The NeoGenix Extraction Allograft is a new biomaterial developed by Neoss, designed to simplify bone regeneration in dental procedures.
What are the main components of NeoGenix?
This allograft consists of 100% human allograft bone fiber and bone particulate, promoting optimal bone growth.
How does NeoGenix benefit dental professionals?
It provides a streamlined, efficient solution that reduces complexity by combining both cortical and cancellous materials.
Who is the Managing Director of Neoss?
John Chopack serves as the Managing Director of Neoss and shares insights about the company's innovations.
What advantage does NeoGenix offer over traditional grafts?
NeoGenix offers a predictable and reliable outcome, making it an economical alternative to xenografts and synthetic products.
